Pharmacy NNN Financing: 2026 Guide for CVS and Walgreens Net Lease Investors

Pharmacy NNN: The Investment Case in 2026

CVS Health and Walgreens Boots Alliance dominate the U.S. pharmacy retail landscape, with CVS operating more than 9,000 locations and Walgreens maintaining a substantial national footprint. Both companies provide essential healthcare services, positioning pharmacy locations as defensive assets in most market conditions.

CVS Health carries investment-grade credit from Standard & Poor's (BBB rating). The company has successfully integrated MinuteClinic services into its pharmacy locations, reinforcing the strategic value of store locations and reducing vacancy risk. CVS's healthcare transformation means the company is less likely to close pharmacies, making CVS-leased properties attractive to long-term investors.

Walgreens Boots Alliance historically carried strong credit, but as of 2025, the company's rating stands at BB+, placing it just outside investment grade. Walgreens has faced profitability pressures and has been rationalizing store count, which has introduced additional scrutiny from lenders and investors. Despite the credit pressure, Walgreens remains a viable NNN tenant, though with wider spreads and tighter lending terms than CVS.

A typical pharmacy store spans 14,000 to 15,000 square feet and occupies a prominent corner or pad site location with a drive-through. These characteristics ensure high visibility and customer convenience, supporting consistent traffic and sales.

In 2026, cap rates for pharmacy NNN investments reflect tenant credit quality and lease structure:

• CVS ground lease: 5.0% to 6.5%
• CVS fee simple: 5.75% to 7.0%
• Walgreens ground lease: 5.75% to 7.0%
• Walgreens fee simple: 6.5% to 7.75%

The wider Walgreens spread reflects lender and investor concerns about tenant credit deterioration and store closure risk.

Ground Lease vs Fee Simple: How It Changes Everything

The distinction between ground lease and fee simple pharmacy assets fundamentally affects valuation, financing, and long-term risk profile.

Ground Lease Structure: The investor (landlord) owns the land only; the pharmacy tenant owns the building and all improvements. Ground leases typically feature a 25-year primary term with renewal options, absolute NNN provisions, and flat or nominal rent increases over the lease period. Because the tenant owns the building and is responsible for all maintenance and improvements, the landlord's obligations are minimal. This structure is particularly attractive to life insurance company lenders, whose long-duration liability matches the 25-year lease horizon. Ground lease pharmacies command higher valuations than fee simple equivalents because the investor's capital requirements are lower, and residual building risk transfers to the tenant.

Fee Simple Structure: The investor owns both the land and the building. Fee simple is more common for older pharmacy buildings constructed between the 1990s and 2010s. While the investor retains building equity, the property carries obsolescence risk if the pharmacy tenant exits. Building value depends on the ability to repurpose the asset for alternative uses (quick-serve restaurants, medical offices, or other retail), which varies by location and market condition. Fee simple pharmacies typically command higher cap rates than ground lease equivalents, reflecting the building risk.

Lenders treat these structures differently. A ground lease with a 25-year term and investment-grade credit tenant is viewed as a long-duration, lower-risk asset. A fee simple property, even with the same tenant and lease term, carries building obsolescence risk and typically experiences tighter leverage and higher pricing from lenders.

Lender Options by Deal Type and Size

The pharmacy NNN lender landscape varies by deal structure, size, and tenant credit quality.

Ground Lease (Typical range: $3 million to $15 million): Life insurance company lenders are the preferred source for ground lease pharmacy assets. These lenders have long-duration liabilities that align with 25-year lease terms, and they view ground leases as stable, income-producing investments. Typical loan terms include 60% to 65% loan-to-value (LTV), 1.25x debt service coverage ratio (DSCR), and fixed-rate financing over 25 to 30 years. For CVS ground leases, execution is straightforward. Walgreens ground leases may encounter slightly tighter LTV (59% to 62%) and higher pricing (25 to 50 basis points wider spreads).

Fee Simple (Typical range: $1.5 million to $10 million): Fee simple pharmacy financing is available through multiple channels depending on deal size. For smaller deals ($1 million to $5 million), banks with recourse are viable sources. For larger fee simple pharmacies ($5 million and up), CMBS conduits are competitive, typically offering 65% to 70% LTV and allowing non-recourse structures. CMBS execution works well for fee simple pharmacies with strong credit tenants and proven operating histories.

Walgreens Credit: What Lenders Think in 2026

Walgreens credit deterioration is the defining issue in pharmacy NNN financing in 2026. Since 2023, Walgreens has faced significant headwinds: declining store profitability, ongoing store closures, and margin compression driven by generic drug pricing pressure and payer reimbursement cuts. The company's shift to a BB+ rating signals increased financial stress.

For investors and lenders, Walgreens credit implications are concrete:

• Ground lease Walgreens properties price at 75 to 100 basis points higher cap rates than equivalent CVS ground leases.
• Some lenders have tightened LTV by 3% to 5% for Walgreens compared to CVS, reflecting elevated risk.
• New Walgreens leases feature shorter initial terms (10 to 15 years) rather than the 25-year standard, reducing investor appeal and increasing refinancing risk.
• Lenders require robust diligence to confirm the property is on a corporate lease (not a sublease or franchise arrangement) and that the location is not on any internal store closure watch list.

Despite these headwinds, Walgreens remains financeable. However, investors should carefully evaluate store-level performance, local market dynamics, and Walgreens' strategic plans for the specific property before committing capital.

Underwriting Standards for Pharmacy NNN

Lender underwriting for pharmacy NNN follows these general parameters in 2026:

• LTV: Ground leases typically 60% to 65%; fee simple 65% to 70%. CVS properties may achieve the higher end of the range; Walgreens typically lower.
• DSCR: 1.25x to 1.35x minimum. Ground leases often underwritten to 1.25x; fee simple closer to 1.30x to 1.35x.
• Lease term remaining: Life insurance companies prefer 15+ years remaining on primary term. Banks are comfortable with 7 to 10 years for shorter financing horizons.
• Rent escalation: Most pharmacy NNN leases include flat rent or nominal annual bumps (0% to 1.5%). Escalations do not materially improve debt service coverage in underwriting.
• Dark store risk: If a pharmacy tenant closes but lease obligations continue, lenders examine dark store clauses in the lease. A robust dark store clause caps landlord exposure. CVS properties carry lower dark store risk due to CVS Health's healthcare transformation. Walgreens dark store risk is higher, and lenders price this via higher cap rates.

Pharmacy NNN Market Outlook 2026

CVS Health: CVS continues expanding MinuteClinic and healthcare services, reducing the likelihood of store closures. CVS properties remain highly financeable and command the best pricing from lenders. New CVS locations are rare; most transactions are sale-leaseback arrangements or acquisitions of existing fee simple properties.

Walgreens: Walgreens continues store rationalization, focusing capital on higher-performing locations. Investors should conduct location-specific diligence and verify the store is not on a closure list. New Walgreens leases are less common, and initial terms are shorter than historical norms.

Other operators: Rite Aid filed for bankruptcy in 2023. Avoid Rite Aid NNN transactions unless the property has been restructured under a post-reorganization operator.

Market trends: New pharmacy construction is rare. Most pharmacy NNN volume comes from sale-leaseback transactions (typically CVS) or acquisition of existing assets. Suburban and exurban markets with limited pharmacy competition offer the strongest investment characteristics.

For investors entering pharmacy NNN in 2026, the landscape favors CVS assets, particularly ground leases with strong underlying credit and location attributes. Walgreens opportunities remain viable but require careful underwriting and reflect wider spreads. Successful deals hinge on tenant credit quality, lease structure, and thorough diligence on location-specific performance and strategic relevance to the operator.

Contact CLS CRE at 310.708.0690 or loans@clscre.com to discuss financing for your pharmacy NNN acquisition.